Logotype for Ryman Healthcare Ltd

Ryman Healthcare (RYM) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Ryman Healthcare Ltd

H1 2025 earnings summary

26 May, 2026

Executive summary

  • Net profit after tax fell 50% to $94.4 million for the six months ended 30 September 2024, with negative cash flow from existing operations and a renewed board and executive team, including a new CEO and functional structure.

  • Revenue rose 10% year-over-year to $366.3 million, driven by increased care and village fees, new openings, and higher deferred management fees.

  • Significant business improvement initiatives delivered $18 million in annualised savings, with further cost reductions targeted and a new pricing structure launched.

  • Major accounting policy changes and restatements were implemented for greater transparency and comparability, including DMF revenue recognition and reclassification of development land.

  • No interim dividend declared; dividend policy to be reviewed in FY26.

Financial highlights

  • Net profit before tax and fair value movements was a loss of $79.8 million, down year-over-year; net profit after tax was $94.4 million, down 50% from $187.1 million.

  • Revenue rose to $366.3 million, up 10% year-over-year, while operating expenses increased 18% to $351.7 million.

  • Cash flow from existing operations was -$7.8 million, down $24.8 million year-over-year; cash flow from development improved to -$44.7 million, a $132 million improvement.

  • Gross receipts from ORA sales reached $651.4 million, up 5% year-over-year; gross resale margin compressed to 26.6%.

  • Net interest-bearing debt at period end was $2.56 billion, with gearing at 37.3%.

Outlook and guidance

  • Free cash flow for FY25 now expected to be negative $50–100 million, revised from previous positive guidance, as settlements are deferred into FY26.

  • Capital expenditure guidance reduced to $625–675 million.

  • Delivery/build rate of retirement units and aged care beds expected at the top end of 850–950.

  • Further business improvement savings targeted by end of FY26.

  • Challenging economic and housing market conditions in New Zealand and Victoria expected to persist, impacting settlements and margins.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more